Stock Events

Stock Events

CALLITAS HEALTH INC 

$0
2
+$0+0% Tuesday 17:25

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
19,571
Avg. Volume
3,754
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q3 2016
Q1 2017
Q2 2017
Q3 2017
Q1 2018
Q1 2018
Q2 2018
-0.14
-0.1
-0.05
-0.01
Expected EPS
N/A
Actual EPS
-0.0087

Financials

-239.63%Profit Margin
Unprofitable
2014
2015
2016
2017
2018
2019
546,422.82Revenue
-1.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MPHMF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a large pharmaceutical company that competes in various healthcare sectors, including areas where Callitas Health operates, such as health and wellness products.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson offers a broad range of health products, directly competing with Callitas Health in the pharmaceutical and wellness product markets.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes in the pharmaceutical and healthcare sectors, overlapping with Callitas Health's market in wellness and medical products.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that produces drugs and products in direct competition with Callitas Health's offerings in the health sector.
Merck
MRK
Mkt Cap277.02B
Merck operates in the global healthcare market, producing pharmaceuticals and health products that compete with Callitas Health's portfolio.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories provides a range of healthcare products that compete with Callitas Health, especially in the medical devices and nutrition sectors.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb is involved in the biopharmaceutical industry, competing with Callitas Health in the development and marketing of prescription drugs and therapies.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company competes in the pharmaceutical sector, offering products that could rival Callitas Health's offerings in health solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries directly competes in the generic and specialty medicines sectors, areas where Callitas Health is also involved.
Sanofi
SNY
Mkt Cap110.4B
Sanofi operates globally in pharmaceuticals and healthcare, competing with Callitas Health in several therapeutic and wellness areas.

About

Show more...
CEO
Mr. George Tsafalas
Country
Canada

Listings

0 Comments

Share your thoughts

FAQ

What is CALLITAS HEALTH INC stock price today?▼
The current price of MPHMF is $0 USD — it has increased by +0% in the past 24 hours. Watch CALLITAS HEALTH INC stock price performance more closely on the chart.
What is CALLITAS HEALTH INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CALLITAS HEALTH INC stocks are traded under the ticker MPHMF.
What were CALLITAS HEALTH INC earnings last quarter?▼
MPHMF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CALLITAS HEALTH INC revenue for the last year?▼
CALLITAS HEALTH INC revenue for the last year amounts to 546,422.82 USD.
What is CALLITAS HEALTH INC net income for the last year?▼
MPHMF net income for the last year is -1.31M USD.
In which sector is CALLITAS HEALTH INC located?▼
CALLITAS HEALTH INC operates in the Health & Wellness sector.
When did CALLITAS HEALTH INC complete a stock split?▼
The last stock split for CALLITAS HEALTH INC was on September 20, 2017 with a ratio of 1:10.
Where is CALLITAS HEALTH INC headquartered?▼
CALLITAS HEALTH INC is headquartered in Newport, Canada.